{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:50:42Z","timestamp":1795139442960,"version":"4.10.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV000640_2018"],"award-info":[{"award-number":["INV000640_2018"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.08.051","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T20:57:22Z","timestamp":1630184242000},"page":"5858-5865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study"],"prefix":"10.1016","volume":"39","author":[{"given":"Rabab","family":"Batool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Tahir Yousafzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miqdad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahira","family":"Sadaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junaid","family":"Mehmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ashorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Naz Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.051_b0005","doi-asserted-by":"crossref","unstructured":"Theiss-Nyland K, Shakya M et al. Assessing the impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepalese children: a protocol for a phase III, randomized control trial. Clinical Infectious Diseases, 2019. 68 (Supplement_2): p. S67-S73.DOI: 10.1093\/cid\/ciy1106.","DOI":"10.1093\/cid\/ciy1106"},{"key":"10.1016\/j.vaccine.2021.08.051_b0010","unstructured":"mondiale de la Sant\u00e9 O, W.H. Organization. Typhoid vaccines: WHO position paper\u2013March 2018\u2013Vaccins antitypho\u00efdiques: note de synth\u00e8se de l\u2019OMS\u2013mars 2018. Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire, 2018;93(13): 153-172 [cited Mar 01, 2021]; Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/272273."},{"key":"10.1016\/j.vaccine.2021.08.051_b0015","doi-asserted-by":"crossref","unstructured":"Medise BE, Soedjatmiko S et al. Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine. PloS one, 2019;14(2). Available from: https:\/\/doi.org\/10.1371\/journal.pone.0211784.","DOI":"10.1371\/journal.pone.0211784"},{"key":"10.1016\/j.vaccine.2021.08.051_b0020","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Pollard AJ et al. Introduction of typhoid conjugate vaccines in Africa and Asia. Clin Infect Diseases 2019;68(Supplement_1): S27-S30. DOI: 10.1093\/cid\/ciy878.","DOI":"10.1093\/cid\/ciy878"},{"key":"10.1016\/j.vaccine.2021.08.051_b0025","doi-asserted-by":"crossref","unstructured":"Theiss-Nyland K, Qadri F et al. Assessing the impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infection among Bangladeshi children: a protocol for a phase IIIb trial. Clinical Infectious Diseases, 2019. 68(Supplement_2): p. S74-S82; Available from: https:\/\/doi.org\/10.1093\/cid\/ciy1107.DOI: 10.1093\/cid\/ciy1106.","DOI":"10.1093\/cid\/ciy1107"},{"key":"10.1016\/j.vaccine.2021.08.051_b0030","unstructured":"University of Washington. Institute for Health Metrics and Evaluation; 2019 [cited 22 June 2021 ]; Available from: http:\/\/ghdx.healthdata.org\/gbd-results-tool."},{"key":"10.1016\/j.vaccine.2021.08.051_b0035","doi-asserted-by":"crossref","unstructured":"Yousafzai MT, Irfan S et al. Burden of culture confirmed enteric fever cases in Karachi, Pakistan: Surveillance for Enteric Fever in Asia Project (SEAP), 2016\u20132019. Clinical Infectious Diseases, 2020;71(Supplement_3): S214-S221.DOI: 10.1093\/cid\/ciaa1308.","DOI":"10.1093\/cid\/ciaa1308"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.051_b0040","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(18)30350-5","article-title":"Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance","volume":"19","author":"Andrews","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.051_b0045","doi-asserted-by":"crossref","unstructured":"Barkume C, Date K et al. Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP): an overview and lessons learned. The Journal of infectious diseases 2018;218(suppl_4):S188-S194.DOI: 10.1093\/infdis\/jiy522.","DOI":"10.1093\/infdis\/jiy522"},{"key":"10.1016\/j.vaccine.2021.08.051_b0050","unstructured":"FELTP-Pakistan. WEEKLY FIELD EPIDEMIOLOGY REPORT. 2(2); Available from: https:\/\/www.nih.org.pk\/wp-content\/uploads\/2020\/03\/07-FELTP-Pakistan-Weekly-Epidemiological-Report-Feb-03-Feb-09-2020.pdf."},{"key":"10.1016\/j.vaccine.2021.08.051_b0055","doi-asserted-by":"crossref","unstructured":"Klemm EJ, Shakoor S et al. Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. MBio, 2018;9(1):e00105-18. DOI: 10.1128\/mBio.00105-18.","DOI":"10.1128\/mBio.00105-18"},{"key":"10.1016\/j.vaccine.2021.08.051_b0060","doi-asserted-by":"crossref","unstructured":"Mejia N, Qamar F, et al. Typhoid and paratyphoid cost of illness in Pakistan: patient and health facility costs from the Surveillance for Enteric Fever in Asia Project II. Clin Infect Diseases 2020;71(Supplement_3):S319-S335. DOI: 10.1093\/cid\/ciaa1336.","DOI":"10.1093\/cid\/ciaa1336"},{"key":"10.1016\/j.vaccine.2021.08.051_b0065","doi-asserted-by":"crossref","unstructured":"Sahastrabuddhe S, Saluja T. Overview of the typhoid conjugate vaccine pipeline: current status and future plans. Clin Infect Diseases 2019;68(Supplement_1): S22-S26.DOI: 10.1093\/cid\/ciy884.","DOI":"10.1093\/cid\/ciy884"},{"key":"10.1016\/j.vaccine.2021.08.051_b0070","doi-asserted-by":"crossref","unstructured":"Jin C, Gibani MM et al. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial. The Lancet 2017;390(10111):2472-2480.DOI: 10.1016\/S0140-6736(17)32149-9.","DOI":"10.1016\/S0140-6736(17)32149-9"},{"issue":"23","key":"10.1016\/j.vaccine.2021.08.051_b0075","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.051_b0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/vaccines8040697","article-title":"Strategies to improve coverage of typhoid conjugate vaccine (TCV) immunization campaign in Karachi, Pakistan","volume":"8","author":"Qamar","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2021.08.051_b0085","doi-asserted-by":"crossref","unstructured":"Darton TC, Jones C et al. Using a human challenge model of infection to measure vaccine efficacy: a randomised, controlled trial comparing the typhoid vaccines M01ZH09 with placebo and Ty21a. PLoS neglected tropical diseases 2016:10(8); Available from: https:\/\/doi.org\/10.1371\/journal.pntd.0004926.","DOI":"10.1371\/journal.pntd.0004926"},{"key":"10.1016\/j.vaccine.2021.08.051_b0090","doi-asserted-by":"crossref","unstructured":"Verani JR, Baqui AH et al. Case-control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls. Vaccine 2017;35(25):3295\u20133302; Available from: https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.037.","DOI":"10.1016\/j.vaccine.2017.04.037"},{"issue":"9","key":"10.1016\/j.vaccine.2021.08.051_b0095","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1473-3099(19)30425-6","article-title":"Typhoid Vi-conjugate vaccine for outbreak control in Zimbabwe","volume":"19","author":"Olaru","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.051_b0100","doi-asserted-by":"crossref","unstructured":"Khan MI, Soofi SB et al. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan. Vaccine, 2012;30(36):5389-5395.DOI: 10.1016\/j.vaccine.2012.06.015.","DOI":"10.1016\/j.vaccine.2012.06.015"},{"key":"10.1016\/j.vaccine.2021.08.051_b0105","doi-asserted-by":"crossref","unstructured":"Crowcroft NS, Klein NP. A framework for research on vaccine effectiveness. Vaccine, 2018;36(48):7286-7293.DOI: 10.1016\/j.vaccine.2018.04.016.","DOI":"10.1016\/j.vaccine.2018.04.016"},{"key":"10.1016\/j.vaccine.2021.08.051_b0110","doi-asserted-by":"crossref","unstructured":"Luby S, Faizan M. et al. Risk factors for typhoid fever in an endemic setting, Karachi, Pakistan. Epidemiol Infect 1998;120(2):129-138. DOI: 10.1017\/s0950268897008558.","DOI":"10.1017\/S0950268897008558"},{"key":"10.1016\/j.vaccine.2021.08.051_b0115","doi-asserted-by":"crossref","unstructured":"Gasem MH, Dolmans W et al. Poor food hygiene and housing as risk factors for typhoid fever in Semarang, Indonesia. Trop. Med. Int. Health 2001;6(6): 484-490. DOI: 10.1046\/j.1365-3156.2001.00734.x.","DOI":"10.1046\/j.1365-3156.2001.00734.x"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.051_b0120","first-page":"899","article-title":"Case-control study to identify risk factors for paediatric endemic typhoid fever in Santiago, Chile","volume":"63","author":"Black","year":"1985","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2021.08.051_b0125","first-page":"37","article-title":"Multidrug resistant Salmonella typhi outbreak in metro Manila, Philippines","volume":"26","author":"Tinaya-Superable","year":"1995","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2021.08.051_b0130","unstructured":"Neuzil DK. More typhoid conjugate vaccines, more impact. Available from: https:\/\/www.coalitionagainsttyphoid.org\/moretyphoidconjugatevaccines\/."}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2022.03.019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21010999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21010999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T04:03:44Z","timestamp":1701317024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21010999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":26,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X21010999"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.051","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.vaccine.2022.03.019","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}